Flowers, Christopher R.

Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society

Wolf, A. M. D., Fontham, E. T. H., Church, T. R., Flowers, C. R., Guerra, C. E., LaMonte, S. J., Etzioni, R., McKenna, M. T., Oeffinger, K. C., Shih, Y. T., et al. (2018) · CA: A Cancer Journal for Clinicians

Colorectal Cancer Screening and DetectionColorectal Cancer Surgical Treatments

Cited by 1,944

2016 US lymphoid malignancy statistics by World Health Organization subtypes

Teras, L. R., DeSantis, C. E., Cerhan, J. R., Morton, L. M., Jemal, A., & Flowers, C. R. (2016) · CA: A Cancer Journal for Clinicians

Lymphoma Diagnosis and TreatmentGlobal Cancer Incidence and Screening

Cited by 1,125

Genetic and functional drivers of diffuse large B cell lymphoma

Reddy, A., Zhang, J., Davis, N. S., Moffitt, A. B., Love, C. L., Waldrop, A., Leppa, S., Pasanen, A., Meriranta, L., Karjalainen-Lindsberg, M.-L., et al. (2017) · Cell

Lymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and Treatment

Cited by 1,104

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.

Fontham, E. T. H., Wolf, A. M. D., Church, T. R., Etzioni, R., Flowers, C. R., Herzig, A., Guerra, C. E., Oeffinger, K. C., Shih, Y. T., Walter, L. C., et al. (2020) · CA A Cancer Journal for Clinicians

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 968

Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline

Flowers, C. R., Seidenfeld, J., Bow, E. J., Karten, C., Gleason, C., Hawley, D. K., Kuderer, N. M., Langston, A. A., Marr, K. A., Rolston, K. V. I., et al. (2013) · Journal of Clinical Oncology

Neutropenia and Cancer InfectionsAntifungal resistance and susceptibility

Cited by 448

Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.

Taplitz, R. A., Kennedy, E. B., Bow, E. J., Crews, J., Gleason, C., Hawley, D. K., Langston, A. A., Nastoupil, L. J., Rajotte, M., Rolston, K., et al. (2018) · Journal of Clinical Oncology

Neutropenia and Cancer InfectionsAntifungal resistance and susceptibility

Cited by 426

A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

Stein-Thoeringer, C. K., Saini, N. Y., Zamir, E., Blumenberg, V., Schubert, M.-L., Mor, U., Fante, M. A., Schmidt, S., Hayase, E., Hayase, T., et al. (2023) · Nature Medicine

CAR-T cell therapy researchGut microbiota and health

Cited by 255

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

Machiela, M. J., Lan, Q., Slager, S. L., Vermeulen, R. C. H., Teras, L. R., Camp, N. J., Cerhan, J. R., Spinelli, J. J., Wang, S. S., Nieters, A., et al. (2016) · Human Molecular Genetics

Telomeres, Telomerase, and SenescenceGenetic Associations and Epidemiology

Cited by 58

Perceptions of clinical care and research among African-American patients with lymphoma

Dance, K. V., Imbody, C. B., Chen, L., McNeill, L., Payne, J. B., & Flowers, C. R. (2021) · Leukemia & Lymphoma

Ethics in Clinical ResearchLymphoma Diagnosis and Treatment

Cited by 7